Evidence map›Paper›PMID 26275954›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Response.

Qian Zhong, Hong-Ling Peng, Xia Zhao, Lin Zhang, Wei-Ting Hwang

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Qian ZhongDepartment of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, P.R. China.
Hong-Ling PengDepartment of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, P.R. China.
Xia ZhaoDepartment of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, P.R. China.
Lin ZhangOvarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania. whwang@mail.med.upenn.edu linzhang@mail.med.upenn.edu.
Wei-Ting HwangOvarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania. Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania. whwang@mail.med.upenn.edu linzhang@mail.med.upenn.edu.

Funding

Therapeutic Micro RNA Strategies for Ovarian CancerP50CA083638 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI GODWIN, ANDREW K., GOLEMIS, ERICA A. · 1999 to 2013
$33.6M
The role of microRNA, mir-30d, in the initiation and progression of cancerR01CA142776 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ZHANG, LIN · 2010 to 2014
$1.6M
NCI NIH HHS P50 CA083638NCI NIH HHS R01 CA142776
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRCA1 ProteinBRCA2 ProteinBreast NeoplasmsFemaleHumansOvarian NeoplasmsBRCA1 ProteinBRCA2 Protein

Identifiers

PMID26275954
PMCPMC4538982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.